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Zdhhc13-dependent Drp1 
S-palmitoylation impacts 
brain bioenergetics, anxiety, 
coordination and motor skills
Eleonora Napoli1, Gyu Song1, Siming Liu1, Alexsandra Espejo  2, Carlos J. Perez2, Fernando 
Benavides2 & Cecilia Giulivi  1,3
Protein S-palmitoylation is a reversible post-translational modification mediated by palmitoyl 
acyltransferase enzymes, a group of Zn2+-finger DHHC-domain-containing proteins (ZDHHC). Here, 
for the first time, we show that Zdhhc13 plays a key role in anxiety-related behaviors and motor 
function, as well as brain bioenergetics, in a mouse model (luc) carrying a spontaneous Zdhhc13 
recessive mutation. At 3 m of age, mutant mice displayed increased sensorimotor gating, anxiety, 
hypoactivity, and decreased motor coordination, compared to littermate controls. Loss of Zdhhc13 
in cortex and cerebellum from 3- and 24 m old hetero- and homozygous male mutant mice resulted 
in lower levels of Drp1 S-palmitoylation accompanied by altered mitochondrial dynamics, increased 
glycolysis, glutaminolysis and lactic acidosis, and neurotransmitter imbalances. Employing in vivo 
and in vitro models, we identified that Zdhhc13-dependent Drp1 S-palmitoylation, which acting alone 
or in concert, enables the normal occurrence of the fission-fusion process. In vitro and in vivo direct 
Zdhhc13-Drp1 protein interaction was observed, confirming Drp1 as a substrate of Zdhhc13. Abnormal 
fission-fusion processes result in disrupted mitochondria morphology and distribution affecting not 
only mitochondrial ATP output but neurotransmission and integrity of synaptic structures in the brain, 
setting the basis for the behavioral abnormalities described in the Zdhhc13-deficient mice.
Protein S-palmitoylation is a reversible post-translational modification mediated by palmitoyl acyltransferase 
(PAT) enzymes, a group of Zn2+-finger, Cys-rich DHHC-domain-containing proteins [Zdhhc1]. The reversible 
addition of palmitate to Cys residues, by a labile thioester bond, is a dynamic process, unique among lipid modi-
fications1. Palmitoylation increases the lipophilicity of proteins, influencing its subcellular distribution, stability, 
protein-protein interaction, trafficking, and function1,2. Some PATs are associated with abnormal cellular prolif-
eration, particularly in several cancer models3 (and references therein).
Deficits in Zdhhc17 (one of the 23 or 24 PATs from human and rat or mouse, respectively) are associated with 
behavioral, memory and synaptic defects4,5 based on the palmitoylation of substrates relevant to neurogenesis and 
neurotransmission (e.g. SNAP-25, synaptotagmin I, and huntingtin (Htt)4,6). Deficits in another PAT, Zdhhc13, 
were linked to alopecia, amyloidosis and osteoporosis7,8 and to behavioral deficits5 linked also to lower Htt pal-
mitoylation5,9. To date, limited information is available on the functional connection between behavioral deficits 
and the substrates for these PATs.
Recently, we described the luc mice, carrying a naturally occurring recessive mutation on Zdhhc133. This 
loss-of-function allele (Zdhhc13luc) was confirmed as a nonsense substitution, resulting in a premature stop codon 
(L203X)3. Phenotypically, homozygous Zdhhc13luc/Zdhhc13luc (luc/luc, luc, homozygous or HOM) mice presented 
a generalized hypotrichosis with increased susceptibility to chemically induced skin carcinogenesis, whereas 
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heterozygous (HET) mice had normal phenotypic appearance3. The Zdhhc13 KO mice, developed by Dr. Hayden’s 
group, has a skin phenotype similar to the HOM mice and behavior consistent with Huntington’s disease (HD)5.
Given that (i) several mitochondrial proteins with clear roles in intermediary metabolism have been shown 
to be S-palmitoylated in a variety of biological systems10–12 and (ii) alopecia—as observed in our3 and another12 
mouse model of Zdhhc13 deficiency—has been linked to mitochondrial dysfunction13,14, we hypothesized that 
Zdhhc13 loss-of-function would result in deficits in bioenergetics, not necessarily limited to skin, but to other 
highly aerobic organs such as brain resulting in behavioral deficits associated with energy distress and altered 
metabolism of neurotransmitters. While several studies have reported complete S-palmitoylomes, very few have 
identified specific PAT substrates, the effect of this post-translational modification on the target’s function and the 
impact of this change at the whole organism level (behavior).
To this end, we evaluated the impact of Zdhhc13 deficiency on mitochondria activity and dynamics in vitro 
[HeLa and murine neuronal progenitor striatal cells (NPC)] and in vivo (cortex and cerebellum in 3- and 24-m 
old HET and HOM male mice) complemented by behavioral assessments (3-m old) of the C57BL/6NJ-luc/luc 
mice and littermate controls.
Our results indicated that Zdhhc13, acting via S-palmitoylation of Drp1, alone or acting in concert, is critical 
for sustaining cortex and cerebellum mitochondrial dynamics and function resulting in deficits in motor- and 
non-motor skills. This study, for the first time, shows that S-palmitoylation constitutes a critical component of the 
post-translational modifications of mitochondrial targets in the brain, affecting basic mitochondrial functions 
and behavior.
Results
Loss of Zdhhc13 results in behavioral deficits. For this study, we generated a full-congenic C57BL/6NJ-
luc/luc strain (N10) with the nonsense mutation in Zdhhc13. HOM mice are distinguished from WT littermates 
because of the generalized hypotrichosis and the characteristic lack of hair around their eyes. No apparent differ-
ences are observed between HET and WT mice (Fig. 1a). No other differences across genotypes were observed 
including the functional observation battery except for the baldness (Supplementary Figs S1–S2). For this study, 
only male mice were used to avoid confounding effects arising from estrous cycles.
Reduced Zdhhc13 gene expression (>50%) was observed in skin, brain and lungs of HOM mice compared 
to WT (Fig. 1b). Zdhhc13-dependent protein S-palmitoylation was tested in cerebella from WT and HOM mice 
by using the acyl-biotin exchange assay (ABE; Fig. 1c). As expected for a nonsense mutation, a significant loss 
of palmitoylated proteins (annotated with lines and respective MW) was noted in both cytosolic and mitochon-
drial membrane fractions, supporting the role of Zdhhc13 as a PAT. These results opened the door for putative 
Figure 1. Skin phenotype, tissue gene expression and S-palmitoylation levels in Zdhhc13 deficiency. (a) Hair 
coat characteristics of luc mice. Pictures taken by Dr. F. Benavides. (b) Zdhhc13 gene expression was performed 
by qPCR in skin, brain and lung from WT and luc mice. Statistical analyses were performed with Student’s t test. 
(c) S-palmitoylation detection in cytosolic and mitochondrial-membranes fractions from cerebellum of WT 
and HOM mice. Bars indicate proteins with decreased palmitoylation levels in HOM vs. WT. Molecular weights 
(in kD) were calculated with the Carestream software based on the MagicMark XP Western Protein Standard. 
Further details are reported in the Methods section. HA = hydroxylamine.
www.nature.com/scientificreports/
3Scientific RepoRts | 7: 12796  | DOI:10.1038/s41598-017-12889-0
functional connections between this post-translational modification in brain mitochondria and their impact on 
both behavior and bioenergetics.
Deficiencies in Zdhhc13 have been linked to Huntington’s disease (HD) characterized by progressive neuro-
pathology and motor deficits5. This inference was supported by the Zdhhc13-dependent S-palmitoylation of Htt 
and by Zdhhc17 and Zdhhc13 both being Htt-interacting proteins with dual functions as PATs and as favoring 
Mg2+ transport6,9,15. Given that the genetic background of our luc mice (C57BL/6NJ) is different than the Zdhhc13 
(Hip14l) KO mice utilized by Dr. Hayden’s group (FVB/N)5 and that genetic background affects the appearance 
of phenotypes even when carrying the same mutations16, behavioral tests (including those representative of the 
HD’s phenotype) were administered to both HOM and HET mice (3-m old). The tests were chosen to evaluate 
disease-specific and gene dose-dependent behaviors, including motor function, endurance, and gait [rotarod17, 
footprint analysis18]; learning and memory [fear conditioning18]; anxiety-related behavior [open field17,19,20]; 
reduction of muscle strength/hypotonia [grip strength21]; and schizophrenia/schizophrenia-like disorders [pre-
pulse inhibition test20].
Motor deficits in luc mice. In the open field test, luc mice spent more time in the periphery and were overall 
less active (i.e., shorter distance traveled; Fig. 2). By evaluating spontaneous locomotor activity22 (Table 1), 14 
(for HOM) and 8 (for HET) of the 17 outcomes tested confirmed hypoactivity and/or hypolocomotion relative 
to WT. The total distance traveled in the open field test showed a strong gene-dose dependency (R2 = 0.996; 
p = 0.040), with HET and HOM displaying significantly less travelled distance than WT (mean distance decreased 
by 30% and 70% of WT, respectively; p < 0.0001). Decreased stereotypic, horizontal and vertical movements were 
recorded in HOM only, whereas increased time spent stationary vs. mobile, as well as decreased number of clock- 
or counterclock-wise revolutions were significant in the luc mice relative to WT (Table 1).
Figure 2. Evaluation of locomotor activity, coordination, gait and anxiety in luc mice. Representative outcomes 
are shown for 3-m old WT (n = 8), HET (n = 8) and HOM (n = 9; see Methods for details). All outcomes data 
are shown as mean ± SEM for each genotype and statistical analysis was performed by ANOVA followed by 
Bonferroni’s post-hoc test, unless otherwise noted. P values are reported right below each test. Other activities 
and locomotion parameters recorded are shown in Table 1 and Supplementary Fig. S2. P values are as follows. 
Open field: <0.0001 for a,b,g; 0.0021; 0.007 for d,i; 0.03 for e,j; 0.045 for f; 0.029 for h. Rotarod: Statistical 
analysis was performed with a 2-way ANOVA, using time and genotype as factors for the analysis, followed by 
Bonferroni’s post-test for multiple comparisons. P values are as follows: 0.0039 for a,b; 0.017 for c; 0.0009 for d; 
0.0076 for e; 0.0005 for f; 0.0404 for g; 0.0064 for h; 0.013 for i; 0.030 for j; 0.0027 for k; 0.018 for l and o; 0.0022 
for m; 0.021 for n. Acoustic startle response: *p = 0.014 **p = 0.0085 vs WT. Treadmill: Reported are outputs 
significantly different among the three groups. P values are as follows: 0.049 for a,b; 0.0063 for c; 0.018 for d; 
0.036 for e; 0.045 for f; 0.0037 for g; 0.0302 for h; 0.0037 for i,j; 0.044 for k; 0.028 for l; 0.0082 for m; 0.019 for n; 
0.0058 for o and p; 0.028 for q; 0.0097 for r; 0.0002 for s.
www.nature.com/scientificreports/
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Luc mice show deficits in hind limb muscle strength. Deficits in muscle strength of hind- (not fore-) limbs 
assessed by the grip strength test were significant for HOM vs. WT (lower by 20%; p = 0.0063; Supplementary 
Fig. S2).
The treadscan (treadmill) analysis showed robust gait anomalies in luc mice. This test entails a thorough analysis 
of the animal’s gait when prompted to walk (as opposed to the open field which is self-initiated; Fig. 2). The num-
ber of strides was significantly higher (by 2-fold) in HOM mice accompanied by shorter stride distances (~50% of 
either WT or HET). The stride and swing times were shorter in HOM mice than WT and HET (by ~50%). These 
results indicated that HOM mice take more and shorter steps than WT or HET with no statistically significant 
differences in speed among the three genotypes (Supplementary Fig. S2).
For luc mice, the track width was longer for all 4 paws (by 20%) suggesting the need for a wider support base. 
The average print area was bigger for front and rear limbs on the left side (by 20%) with no differences for the 
right side. The significantly shorter limb swing times, broader track width with a broader average print area for 
left limbs in luc mice appear to stem from a balance deficit and/or trunk instability that is somehow compen-
sated. Considering that spared white matter (after brain injury) correlates with various open-field and treadmill 
assessment measures in rodents (references therein23), these results may lend support that white matter-mediated 
behavioral functions may be negatively affected by Zdhhc13 deficiency similar to the hypomorphic Hip14-gt 
(gene-trapped) mouse with decreased Zdhhc17 expression in which deficits were observed in astrocytes and 
oligodendrocytes11.
Luc mice show coordination deficits but no learning or memory impairments. By utilizing a rotarod (gold stand-
ard test of motor coordination, fatigue resistance and balance in rodents), we evaluated latency to fall, total 
run time, and speed as indexes of motor activity, coordination and balance. A significant genotype effect was 
observed initially on time to fall from the rotarod or the speed at which mouse fell/flipped (HOM and HET; 
Fig. 2). Comparisons of the performance of mice over time showed that, in general, mutants showed intact motor 
skill learning capacity, albeit slower than WT, catching up with them by day 3.
No statistically significant genotype differences were recorded for the passive-avoidance/learning test (Fig. 2) 
indicating that the luc mice remembered which of a two-compartment chamber was paired with the aversive 
stimulus. Thus, the memory capacity and learning (this test and rotarod performance over time) were not 
impaired in luc mice.
Luc mice show anxiety-like behavior. The time spent in center area vs. the outer margin of the arena during the 
open field test was significantly shorter in HOM (by 63%; p = 0.05) than either HET or WT indicating increased 
anxiety-like behavior. A small, but significant effect on distance travelled in the center was observed for HOM 
only (decreased by 64% of WT and HET; p = 0.01).
Outcome WT HET HOM ANOVA P values R2 Regression P values
Total horizontal activity (counts) 12999 ± 1216(a) 13928 ± 858(b) 7862 ± 413(a)(b) (a)0.0015 (b)0.0003 0.618 0.424
Average horizontal activity (counts) 217 ± 20(a) 232 ± 14(b) 150 ± 11(a)(b) (a)0.0041 (b)0.0007 0.589 0.443
Total distance (cm) 13043 ± 1059(a, b) 7563 ± 671(a, c) 3155 ± 172(b)(c) (a)(b)<0.0001 (c)0.010 0.996 0.040
Total number of moves (counts) 641 ± 44(a) 711 ± 33(b) 329 ± 19(a)(b) (a)(b)<0.0001 0.588 0.443
Moving time (s) 1584 ± 153(a)(b) 722 ± 63(a)(c) 339 ± 15(b)(c) (a)(b)<0.0001 (c) 0.035 0.953 0.139
Rest time (s) 1373 ± 293(a)(b) 2878 ± 63(a) 3237 ± 28(b) (a)(b)<0.0001 0.890 0.217
Vertical activity (rearing) (counts) 764 ± 122(a) 914 ± 87(b) 398 ± 65(a)(b) (a)0.025 (b)0.0012 0.475 0.516
Number of vertical moves (counts) 372 ± 31(a) 389 ± 29 (b) 146 ± 16 (a)(b) (a)(b)<0.0001 0.694 0.373
Vertical time (s) 701 ± 101(a) 617 ± 37(b) 263 ± 35(a)(b) (a)(b)<0.0001 0.888 0.218
Stereotypy (counts) 7554 ± 653(a) 6938 ± 468(b) 4359 ± 411(a)(b) (a)0.0006 (b)0.0045 0.890 0.217
Stereotypy time (s) 872 ± 34(a) 788 ± 19(b) 638 ± 36(a)(b) (a)0.0003 (b)0.0210 0.974 0.103
Clock-wise revolutions (counts) 87 ± 15(a)(b) 26 ± 5(a) 11 ± 1(b) (a)0.0003 (b)<0.0001 0.890 0.228
Counter-clockwise revolutions 
(counts) 95 ± 15
(a)(b) 25 ± 2(a) 10 ± 1(b) (a)(b)<0.0001 0.880 0.214
Left front quadrant time (s) 702 ± 166(a)(b) 189 ± 11(a) 147 ± 37(b) (a)0.0070 (b)0.0025 0.806 0.290
Right front quadrant time (s) 414 ± 78(a) 161 ± 6(a) 220 ± 66 (a)0.0070 0.537 0.476
Left rear quadrant time (s) 698 ± 125 534 ± 129 661 ± 223 0.05 0.862
Right rear quadrant time (s) 451 ± 50(a) 219 ± 36(a) 273 ± 66 (a)0.0170 0.538 0.476
Table 1. Measured outcomes for the assessment of spontaneous locomotor activity. Data are shown as 
mean ± SEM. n = 8 for WT and HET; n = 9 for HOM. Statistical analysis was performed by ANOVA followed by 
Bonferroni’s pairwise comparison post-hoc test. Counts: number of movements recorded by the beam for any 
given activity; Moving time: total time animal was moving; Rest time: Total time animal was not moving; Vertical 
time: Amount of time spent in vertical plane. Gene-dose dependency was evaluated for all the outcomes with a 
regression analysis built considering WT, HET and HOM as carrying respectively 0, 1 and 2 mutant alleles.
www.nature.com/scientificreports/
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Prepulse inhibition (PPI) of startle test shows increased sensory-gating activity in luc mice. While the results of the 
open field test may reflect increased anxiety, the observed hypoactivity or hypolocomotion of luc mice may con-
found this inference. Thus, a separate test for anxiety-like behaviors (i.e., PPI of startle test24) was utilized. In the 
PPI paradigm, a low-level acoustic stimulus (prepulse) is presented ms prior to a high intensity acoustic stimulus 
and whole body startle response is recorded. In healthy mammals, the prepulse significantly dampens the startle 
response to the pulse and the PPI is believed to reflect normal sensory gating of the CNS25. HOM mice showed a 
significant decrease in the maximum PPI, a basic marker of sensorimotor gating, consistent with increased anxi-
ety and excitation of the cortico-striatal pathway (Fig. 2).
Loss of Zdhhc13 results in a brain metabolic status consistent with a switch to aerobic glyco-
lysis. Given the functional connection between anxiety26 and altered motor skills with mitochondrial dys-
function27,28, and the heavy reliance of brain on OXPHOS29–31, we tested brain bioenergetics by evaluating (a) 
mitochondrial Complex activities (along with citrate synthase as a surrogate marker for mitochondrial mass) 
in cerebellum and cortex and (b) cerebellar metabolomics. These regions were selected because Zdhhc13 gene 
expression is higher in cerebellum than cortex (Supplementary Fig. S3) and some are implicated in anxiety disor-
ders (cortex, amygdala, hippocampus, and striatum26,32), and motor skills and coordination (cerebellum, amyd-
gala, hippocampus33). Finally, they can provide enough biological material for testing mitochondrial outcomes, 
and overall reduction in Zdhhc13 levels was assumed in all brain regions because this mouse model is not condi-
tional or region-specific.
Cerebella from 3-m old HOM mice showed a significant decline in normalized Complex IV activity (by 33%; 
Fig. 3), with no significant changes for Complex I, V, or citrate synthase activities and mitochondrial DNA copy 
number (mtDNA CN; Fig. 3). No significant differences were observed for any mitochondrial outcomes tested 
between WT and HET cerebella.
Similar to cerebellum, Complex IV activity was also decreased by almost half in cortex of HOM mice (40 and 
53% relative to WT and HET, respectively; Fig. 3), whereas Complex I activity was significantly higher in HET 
(by ~2-fold) than HOM. Complex V activity and mitochondrial mass—as judged by the matrix biomarker citrate 
synthase—were not significantly different among the three groups. The mtDNA CN was significantly lower in 
both HET and HOM, without reaching the threshold for a mtDNA depletion. A 2-way ANOVA showed that 
brain area played a significant role in all the outcomes tested, whereas the genotype was mainly involved in the 
differences recorded for Complex IV. The genotype x brain area interaction influenced mainly Complex IV and 
mitochondrial mass (Fig. 3).
The effect of age on mitochondrial outcomes was tested by assessing Complex I, IV and V activities in cere-
bella of mice at 2 y of age (Fig. 3). The activity of Complex IV in HOM cerebella was almost 50% of that of either 
WT or HET whereas that of Complex V was nearly one-third. The deficits in these Complexes (normalized by 
mitochondrial mass) were magnified by the increased activity of citrate synthase (1.3-fold in HOM vs. HET or 
Figure 3. Effect of age and Zdhhc13 deficiency on brain mitochondrial outcomes. Cerebellar and cortical 
activities of Complex I, IV and V, expressed as nmol x (min x mg protein)−1, were normalized by citrate 
synthase activity. These outcomes were obtained from 3-m old WT (n = 3), HET (n = 8), HOM (n = 8) mice 
after the behavioral testing was performed, or from 2-y old WT (n = 12), HET (n = 6), HOM (n = 6). Statistical 
analysis was performed via 2-way ANOVA to evaluate the effect of genotype, time and their interaction on the 
total variance. In bold are statistically significant effects, and between parentheses are values of F (DFn, DFd). 
Bonferroni’s post-hoc test for multiple comparisons was also performed and statistically significant p values are 
as follows: a, b, e, f, g, h = <0.0001; c = 0.0102; d = 0.0014; i = 0.0003; j = 0.0002. All other details were included 
in the Methods section and Supplementary Methods.
www.nature.com/scientificreports/
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WT; Fig. 3) but not completely accounted for by this increase. A 2-way ANOVA revealed that age had the strong-
est effect on all outcomes tested (Fig. 3) whereas genotype influenced the most Complex IV activity and mito-
chondrial mass. The interaction between age and genotype was statistically significant only for mitochondrial 
mass (citrate synthase activity; Fig. 3).
Considering the critical role of mitochondria in intermediary metabolism and neurotransmission, untargeted 
cerebellar metabolomics was performed to elucidate the role of the metabolic flow of substrates in the absence 
of Zdhhc13. A total of 214 metabolites were obtained, from which 121 were identified. From these, 18 were 
found statistically significantly different in at least one of the paired comparisons (WT-HET and/or WT-HOM; 
Fig. 4). The majority of these metabolites (67%) were more abundant in HOM cerebella than WT including the 
lactate-to-pyruvate (L/P) ratio. The increase in this ratio suggested a shift towards aerobic glycolysis. Using these 19 
outcomes, pathway over-representation analysis was performed34, and from these, those with an FDR < 0.05 were 
selected (shown in red). The TCA cycle, glyoxylate, dicarboxylate and pyruvate metabolism were over-represented 
with Zdhhc13 deficiency (Fig. 4). Other pathways (with a raw p < 0.05 but with FDR > 0.05) included glycolysis, 
glycerolipid metabolism, pentose phosphate pathway, metabolism of several amino acids and ascorbate (Fig. 4, path-
ways 4–14). These metabolic changes are consistent with a shift from OXPHOS to glycolysis (increased L/P ratio, 
Fig. 4) accompanied by the use of both glucose and glutamine as fuels. While glucose generates ATP via glycolysis, 
this pathway also provides the synthesis of precursors for other biomolecules such as 3-phosphoglycerate for serine, 
glycine and alpha-ketoglutarate (AKG), and dihydroxyacetone phosphate (the latter used as the carbon skeleton 
for triacylglycerol synthesis). In this regard, the increased citrate concentration observed with Zdhhc13 deficiency 
seems to arise from increased reductive carboxylation of AKG to favor fatty acid synthesis (Fig. 5). The relatively 
lower levels of palmitic and arachidic acids seem to point to an increased triacylglyceride synthesis whereas increases 
in arachidonic acid may favor the production of prostaglandins and tromboxanes (Fig. 5). Taken together, these 
results show an increased anaerobic glycolysis likely to support biosynthetic pathways required for rapid cellular 
proliferation35, as well as support for synapse formation and growth30.
Remarkably, as the primary energetic costs in brain are associated with neurotransmission29,31, the increased levels 
of glutamate and glutamine in luc cerebella along with the higher levels of the γ-aminobutyric acid cyclization product, 
2-pyrrolidinone (1.24-fold; p = 0.128 and 1.36-fold; p = 0.041 in HET and HOM of controls, respectively) are suggestive 
of a neurotransmitter imbalances, which could partly account for the abnormal behavior observed in luc mice.
Figure 4. Untargeted metabolomics of cerebella from WT, HET and HOM mice. This analysis was performed 
in cerebella from 3-m old WT (n = 3), HET (n = 6) and HOM (n = 6) luc mice. Levels of metabolites statistically 
significantly different in at least one of the paired comparisons (WT-HET and/or WT-HOM) are shown. 
Lower panel: Pathway over-representation analysis was run with MetaboAnalyst. The size of the symbols is 
proportional to the impact. In dark gray, pathways with FDR < 0.05. The rest are indicated in light gray. The 
numbers were used to identify each of the pathways.
www.nature.com/scientificreports/
7Scientific RepoRts | 7: 12796  | DOI:10.1038/s41598-017-12889-0
Pharmacological inhibition of Zdhhc13-dependent Drp1 S-palmitoylation halts mitochondrial 
targeting of Drp1 and alters mitochondria distribution. Remodeling of tubular mitochondria influ-
ences the internal diffusion of energy metabolites and proteins, the delivery of newly synthesized ATP to various 
cellular areas, the generation and maintenance of the electron protonmotive force, the stability of the respiras-
omes and the efficiency of OXPHOS36. Based on the following data obtained with luc mice (i) lower Complex 
IV activity accompanied by Complex V deficits observed with age likely as a result of accumulation of damaged 
mitochondria (Fig. 3), (ii) increased shift to aerobic glycolysis (Figs 4 and 5), and (iii) the lower S-palmitoylation 
of a band with MW matching that of Drp1 from luc brains (Fig. 1c), we hypothesized that Zdhhc13 deficiency 
altered the localization and/or activity of Drp1 enabling an altered fusion-fission process. Loss of Drp1 activ-
ity has been identified in several human neurological diseases37–39, with generalized OXPHOS deficiencies with 
or without lower cytochrome c oxidase activity39–41. Drp1 deficiency is generally thought to cause mitochon-
drial dysfunction due to a failure of a Drp1-dependent mechanism of mitophagy that removes damaged mito-
chondria42 in line with the worsening of bioenergetics with age. While two studies reported S-palmitoylation of 
Drp110,43, no functional consequences for this modification were reported.
Mitochondrial and cytosolic fractions from cerebella of WT and HOM mice were used to test for the 
Zdhhc13-mediated subcellular distribution of Drp1. A negligible cytosolic contamination was evidenced by the 
low levels of actin in the mitochondrial fractions and the effectiveness of mitochondria extraction by the lack of 
Vdac detection in the cytosolic fractions (Fig. 6a). Purity of these fractions was supported by the 30 to 300-fold 
enrichment of mitochondrial proteins in the mitochondria fraction (Supplementary Table S1). Levels of cerebel-
lar Drp1 from WT and HOM mice, as judged by western blots, was not different in the cytosol (normalized by 
actin) but showed a significant decrease in the mitochondrial fraction (normalized to Vdac) of the HOM mice 
(~50% of WT; Fig. 6a).
Consistent with these results, specific pharmacological inhibition of S-palmitoylation in NPC obtained with 
exposure to 20 µM 2-bromo-palmitate15 for 6 h, decreased significantly the co-localization of Drp1 with mito-
chondria by ~50% both in confocal (Fig. 6b) and immunoblotting experiments (Fig. 6c). As observed with the 
younger mice, normalized Complex IV activity in 2-bromopalmitate-treated cells was lower than vehicle-treated 
(by ~50%) whereas normalized Complex V activity was not affected (Fig. 6d). Of note, mitochondria morphol-
ogy, distribution and mass (visualized by using MitoTracker Red, which specifically stains polarized mitochon-
dria) in 2-bromo-palmitate- vs. vehicle-treated NPC (Fig. 6b; compare subpanels a and c) showed a significant 
decline in functional mitochondria (normalized per cell area; p = 0.035), accompanied by increased perikarya 
clustering compared to the more evenly distributed mitochondrial network in vehicle-treated NPC. This pat-
tern was similar to mammalian systems with loss of Drp1 in which disrupted morphology (depending on cell 
type44,45), nuclear clustering, mitochondria hyperdensity and increased spheres/globules46,47 was reported.
Similar results and consistent with this idea, L203X Zdhhc13-overexpressing HeLa cells relative to WT 
Zdhhc13-overexpressing cells had lower polarized mitochondrial mass (by 21%), lower Drp1 in mitochondrial 
foci (by 23% normalized to polarized mitochondria; p = 0.044; Supplementary Figure S4), with a more compact 
Figure 5. Scheme representing differences in metabolic flow of substrates in the presence of Zdhhc13 loss-of-
function. Metabolites with differential levels in cerebella from WT and luc mice (from Fig. 4) are shown in light 
gray (higher abundance in luc than WT) and in italics (lower levels in luc than WT). Gray arrows indicate lower 
flux whereas black, enhanced pathways.
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mitochondrial distribution, possibly due to the presence of a hyperfused mitochondrial network, with no dif-
ferences in the amount of total (cellular) Drp1 between groups (Supplementary Results and Supplementary 
Fig. S4).
Thus, inhibition of Drp1 S-palmitoylation or overexpression of L203X Zdhhc13 results in a significant altered 
mitochondria distribution extending the results obtained in vivo.
Zdhhc13 interacts with Drp1 in vivo and in vitro. Acyl-biotin exchange (ABE) assays followed by 
immunoprecipitation experiments showed that Drp1 S-palmitoylation normalized to total Drp1 was signifi-
cantly decreased in cerebella from HOM mice (by >90% of WT or HET; Fig. 6e), confirming Drp1 as a key 
substrate of Zdhhc13. Further experimental confirmation of the S-palmitoylation activity of Zdhhc13 towards 
Drp1 was provided by showing their physical interaction in both in vitro and in vivo experiments. In vitro assays 
included the use of GST-tagged WT or L203X Zdhhc13 proteins immunocaptured by a high affinity anti-GST 
antibody pre-immobilized on a ForteBio Octet RED384 System biosensor and using recombinant, purified Drp1 
(56, 167 and 500 nM; Fig. 6f). This analysis resulted in kassociation, kdissociation and KD of respectively 8.2 × 104 M−1x 
s−1, 4.6 × 10−2 s−1 and 5.6 × 10−7 M for the WT and 2.1 × 104 M−1x s−1, 1.8 × 10−3 s−1 and 8.8 × 10−8 M for the 
L203X Zdhhc13. These results indicated that Drp1 interacted strongly with both the WT and truncated forms of 
Zdhhc13, with the latter having a 6-fold higher affinity for Drp1 than the WT, but with no palmitoylating activity.
To avoid putative confounding effects of the GST tag, immunoprecipitation experiments utilizing whole 
brain lysates from WT and HOM mice were performed. Decreased levels of Drp1 were observed in HOM brain 
lysates vs. WT following IP with either anti-Drp1 or anti-Zdhhc13 antibodies (by 44% and 51% relative to WT; 
Fig. 6g and Supplementary Fig. S5). Notably, proteomics analysis revealed only 7 other co-precipitating proteins, 
from which, only one was a mitochondrial protein, the glutamate carrier 1 (GHC1 or SLC25A22; Supplementary 
Table S2).
Figure 6. Evidence of the direct protein interaction between Zdhhc13 and Drp1. (a) Representative cropped 
image of Drp1, VDAC and actin levels in cytosolic and mitochondrial cerebellar fractions from WT, HET 
and HOM mice (n = 3). Data are reported as mean ± SEM. Statistical analysis was performed by ANOVA, 
followed by Bonferroni’s post-hoc test. P values are as follows: a = 0.015; b = 0.049. (b) Mitochondria (red) 
morphology, distribution and mass, and Drp1 levels (green) in NPC vehicle-treated (a,b) and treated (c,d) 
with 20 µM 2-bromo-palmitate for 6 h. Pictures were taken at a 120x magnification. Mitochondrial Drp1 
levels were evaluated using the Image J (Fiji) colocalization plugin and reported as mean ± SEM of ≥10 
fields. Statistical analysis was performed with paired Student’s t test. (c) Drp1, beta-subunit of mitochondrial 
ATPase and actin levels in total and mitochondrial fractions of NPC before and after treatment with 20 µM 
2-bromo-palmitate for 6 h. Densitometry was evaluated with the Carestream software and data are reported as 
mean ± SEM of 2 separate experiments. Statistical analysis performed with paired Student’s t test. (d) Complex 
IV and V activities are shown as either normalized or non-normalized by citrate synthase. Specific activities 
are expressed as nmol x (min × 106 cells)−1. Statistical analysis performed by paired Student’s t test between 
vehicle-treated and bromo-palmitate-treated samples. (e) Cerebellar Drp1 palmitoylation levels (cropped 
images). Immunoprecipitation of Drp1 was followed by ABE assay (see Methods). Levels of S-palmitoylated 
Drp1 normalized to total Drp1 are reported. HA = hydroxylamine. (f) Interaction of purified, recombinant 
Drp1 with full length and truncated GST-tagged Zdhhc13. The kinetics traces were obtained with WT and 
mutant Zdhhc13 at concentrations indicated in the text. Other details, see Methods. (g) Representative cropped 
image showing Drp1 levels in WT and HOM brains upon immunoprecipitation with anti- Drp1 or Zdhhc13 
antibodies. Densitometry analysis was performed with Image J. The antibody heavy chain was used as loading 
control. Statistical analysis was performed with the Student’s t test. Representative full-length western blot 
images are shown in Supplementary Fig. S5.
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Taken together, these results indicated that Zdhhc13 physically interacts with Drp1 (both in vitro and in vivo) 
and that both translocation and activity of Drp1 are strongly modulated by S-palmitoylation.
Discussion
In a previous study, using a positional cloning approach, we have identified a nonsense mutation in exon 7 of 
Zdhhc13 in luc/luc mice3. This T-A substitution, which results in a premature stop codon (L203X), generates 
a truncated form of the ubiquitously expressed Zdhhc13 protein representing a true loss-of-function muta-
tion. Here, we show that Zdhhc13-mediated Drp1 S-palmitoylation, acting alone or in concert with others, is 
critical for sustaining mitochondrial dynamics and function and linked to neurobehavior. To our knowledge, 
this is the first report showing that loss of Drp1 S-palmitoylation by a specific PAT, Zdhhc13, disrupts brain 
mitochondria function and morphology eliciting abnormal behavior fueled by a shift towards glycolysis and 
excitatory-inhibitory neurotransmitter imbalances.
In agreement with a recent study12 conducted in liver of 6-w old Zdhhc13-deficient mice, Zdhhc13 
loss-of-function leads to loss of palmitoylation of cytosolic and mitochondrial proteins in brain. While a database 
search of mitochondrial palmitoylated proteins resulted in >190 proteins in humans and mouse (~26 in rat) with 
an overlap of 121 (including Drp1; Dataset S1), the results presented in this study (i.e., direct protein-protein 
interaction between Zdhhc13 and Drp1 both in vivo and in vitro; decreased S-palmitoylation and mitochondrial 
co-localization in either luc mice or with pharmacological inhibition of S-palmitoylation activity; increased defi-
cits in mitochondrial morphology, distribution and activity) are consistent with Drp1 as one of the substrates of 
Zdhhc13, and that S-palmitoylation of Drp1 (alone or in concert) affects its translocation to mitochondria likely 
contributing to the disrupted distribution and lower OXPHOS observed in vivo.
Lower OXPHOS was evidenced in HOM at 3-m (Complex IV activity) which progressed with age (Complex 
IV, V and citrate synthase), increased glycolysis and glutaminolysis (both HET and HOM), and enhanced perinu-
clear mitochondrial distribution (HeLa and NPC). The lower Complex IV activity from young mice (coupled with 
the decrease in Complex V in older mice) is consistent with other studies on Drp1 deficiency40,41,48. Considering 
the role of Drp1 in the modeling and organization of mitochondrial cristae49 and that disruption of mitochondrial 
fission is linked to impairment of mitochondrial ATP production50, a dysfunctional Drp1 would affect mitochon-
drial fission and mitophagy challenging the recycling of critical lipids for the mitochondrial inner membrane and 
the stabilization of respiratory chain super-complexes51–53. Naturally the relevance of Drp1 S-palmitoylation in 
the context of OXPHOS is enhanced in brain (vs. skin) because neurons are preferentially vulnerable to deficits 
in mitochondrial dynamics39,54,55. Indeed, the 20–30% cellular decrease in polarized mitochondria (in vitro), the 
40–50% decrease in Complex IV activity (in vivo and in vitro), and the increased L/P ratio (in vivo) are consistent 
with the 22% decrease in ATP content in hippocampal mitochondria from conditional Drp1 KO mice45. While 
these deficits may be regarded as non-significant for the cellular energy balance, it is important to indicate that 
neurons rely heavily on mitochondria for localized energy support56. Loss of Drp1 causes depletion of mitochon-
dria from synapses and dendrites57 leading to their structural loss56 and conditional KO mice develop progressive, 
neuronal subtype-specific alterations in mitochondrial shape and distribution in the absence of overt neurode-
generation with lower OXPHOS, ATP content, synaptic reserve pool vesicle recruitment and impaired spatial 
working memory45.
Synaptic dysfunction plays a critical role in the pathogenesis of Alzheimer’s disease58 and, as an extension, may 
elicit the behavioral changes observed in luc mice. The fact that Zdhhc13 deficiency had a major effect on corti-
cal and less on cerebellar bioenergetics may be ascribed to differences in the neuron-to-glia ratio in cortex (1:4 
ratio) vs. cerebellum [4:159] and distinct rates of organelle turnover in these cell types. It is also possible that brain 
area-specific energy demands produce differential mitochondrial turnover rates60,61. Interestingly, differences in 
cortical vs. cerebellar Zdhhc13 requirement for mitochondrial function do not simply follow gene expression 
levels, as Zdhhc13 is expressed mainly in cerebellum more than cortex (Supplementary Fig. S3). These findings 
suggest that Zdhhc13-mediated Drp1 modifications may be also dependent on the presence of brain-specific 
interacting proteins required for mitophagy, fusion-fission processes, or protection of mitochondrial function62 
with more overt mitochondrial deficits in those brain regions with critical roles in the circuitry of anxiety [cortex, 
amygdala, hippocampus, and striatum32], other than those tested here.
In regards to the neurochemistry underlying the behavioral deficits, the cerebellar metabolome was consist-
ent with a switch towards aerobic glycolysis. While this switch will sustain rapid growth and proliferation at the 
expense of lower ATP production, this new steady-state may underlie the increases in glutamate and GABA (the 
major excitatory and inhibitory neurotransmitters, respectively, in the mature mammalian CNS, accounting for 
>90% of synapses63) observed in luc brains. Indeed, the glutamate-glutamine cycle accounts for a major fraction 
of glutamine synthesis64 with a metabolic rate similar to neuronal glucose oxidation31,65. Glutamate and GABA 
play major roles in energy metabolism, cortical excitability and cognitive function65,66. Alterations in Glu and 
GABA pathways could explain the behavioral deficits observed in luc mice as they are associated with many 
neurological and neuropsychiatric disorders such as Alzheimer’s, amyotrophic lateral sclerosis, mood disorders, 
high-functioning children with autism among others67,68. Although not tested in this study, it is conceivable that 
the co-precipitation of the mitochondrial glutamate carrier 1 by Drp1 and Zdhhc13 antibodies (Supplementary 
Table S2) may point to another target of this post-translational modification with critical relevance for neuro-
transmission (manuscript in preparation).
From a neurobehavioral standpoint, and considering the link between Drp1 and neurological diseases44,69, the 
modulation of mitochondrial fission-fusion in the context of S-palmitoylation by Zdhhc13 is of utmost relevance. 
A gene-dose-dependency was observed for the luc mice at 3-m of age in the increased sensory-gating activity, 
hypoactivity or hypolocomotion, decreased motor coordination, and decreased hindlimb grip strength, with no 
impact on learning and/or memory. Some of the subtle differences between HOM and HET in the behavioral and 
biochemical tests, which did not follow a gene-dose dependency, may be ascribed to compensatory processes 
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(e.g., Fig. 2). In regards to behavior, our behavioral findings seem to represent a milder version of some of the 
aspects of HD5 (impaired rapid alternating movements and fine motor skills, dysarthria, ataxia and postural 
instability, gait and stance imbalance, broad-based gait and stance) but not others (cognition and memory19,70). 
The fact that the behavioral deficits in luc mice are not a phenocopy of HD’s features, provides additional evidence 
that Zdhhc13 has other roles than the palmitoylation of Htt (vide infra; also71), recalling some of the behavioral 
manifestations of other human diseases with an ataxia component (http://www.malacards.org/card/ataxia 72). 
Our luc mouse model (truncated Zdhhc13) shows a milder phenotypic version of that developed by Dr. Hayden’s 
KO (gene trapped5). This apparent discrepancy could be bridged by considering that these models were devel-
oped on different genetic backgrounds (C57BL/6NJ vs. FVB/N) as it has been observed in other cases (e.g., ref.16). 
The selection of the genetic background (C57BL/6NJ) of our luca model was based on the fact that the substrain 
C57BL/6 J has a negligible mitochondrial nicotinamide transhydrogenase activity due to a deletion comprising 
the Nnt gene (Supplementary Fig. S6), and as such, an increased background of mitochondrial oxidative stress73, 
which could interfere with the interpretation of our results on bioenergetics, likely leading to the presentation 
of a more severe phenotype. Indeed, the Zdhhc13-deficient mice on a mixed background12 showed poor weight 
gain despite an increased food consumption (factor that may relate to mitochondrial uncoupling or dysfunction) 
whereas no such differences were observed in the luc model.
In summary, for the first time this study shows evidence that increased Drp1 S-palmitoylation is a crucial 
mechanism for the translocation of Drp1 to mitochondria and the normal occurrence of the fission-fusion pro-
cess. Abnormalities in this mechanism result in disrupted mitochondria morphology and distribution, which may 
affect not only cellular energy status but also neurotransmission and the integrity of synaptic structures in the 
brain underlying the behavioral abnormalities described in the luc mice. Considering the role of S-palmitoylated 
proteins in diverse processes, including neural development74, pancreatic beta cell metabolism75, and interme-
diary metabolism (this study and12), among others, we propose Drp1 S-palmitoylation as a novel, active process 
that enables the switch between mitochondria-derived ATP and glycolysis (including Glu and GABA cycles) by 
controlling mitochondria dynamics (Fig. 7) and, ultimately, affecting animal behavior (i.e., motor and non-motor, 
emotional skills). A metabolic deficit that leads to impaired ATP production and neurotransmitter pathways—as 
observed in this study—may explain the behavioral deficits exhibited by the luc model. Although we cannot 
completely exclude the role of other S-palmitoylated proteins (e.g., mitochondrial glutamate carrier 1) as well as 
other brain regions not tested in this study, S-palmitoylation of Drp1, acting alone or in concert (Supplementary 
Table S2), constitutes a novel regulation that has the potential to serve as a springboard to develop strategies for 
generating therapies not only for neurological disorders with energy deficits and/or neurotransmitter imbalances.
Methods
Origin of the luc mutation and phenotyping. The luc mutant allele (Zdhhc13luc) was previously 
described3. The Zdhhc13luc allele was introgressed onto C57BL/6NJ by marker-assisted backcrossing to produce 
a full-congenic strain (C57BL/6NJ.Cg-Zdhhc13luc, N10). Genotyping for the Zdhhc13luc allele was done by direct 
sequencing using PCR primers designed to detect the missense mutation on genomic DNA or by allele-specific 
KASPar PCR assay (Kbioscience, Beverly, MA). Additionally, all mice were also genotyped for the presence of the 
Nnt gene as described under the Supplementary Fig. S6.
Animal housing. All mice were originally housed at MD Anderson Cancer Center Smithville followed NIH 
guidelines (Guide for the Care and Use of Laboratory Animals, 8th Edition, 2010) in a facility accredited by the 
Association for Assessment and Accreditation of Laboratory Animal Care International. Male mice (3-month 
old) were then transferred to UC Davis and housed in the behavioral laboratory facility (Mouse Biology Program, 
UC Davis). At the beginning of experiments, mice were housed, 3–4 per cage separated by genotype in an animal 
room with constant temperature (22 ± 1 °C) and 12 h light/dark cycle (lights on/off at 6:00 a.m/p.m.), with free 
access to food and water. All experiments were performed in the early phase of the light cycle under standard 
Figure 7. Graphical abstract of the role of Zdhhc13 in mitochondria dynamics. In luc mice or through 
pharmacological inhibition of S-palmitoylation, lower S-palmitoylation of Drp1 (Palm-Drp1) leads to 
impaired translocation to mitochondria. This results in an imbalance between the fusion and fission processes, 
interfering with mitophagy and/or segregation of mitochondria into daughter cells. Accumulation of defective 
mitochondria results in lower ATP production, and in the case of neurons, imbalances in neurotransmission. 
Both processes are likely to result in behavioral deficits observed in the luc mice.
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room fluorescent lights. All methods and protocols were carried out in accordance with relevant NIH guidelines 
and regulations and approved by the IACUC Committee at the University of California Davis. Other details on 
animal general health and housing are reported in the Supplementary Methods and in Supplementary Fig. S1.
Behavioral tests. Behavioral testing began 4–6 days after arrival into the animal facility when mice were still 
3-months old. The sequence of experiments was designed from less to more intrusive in order to minimize the 
effects of previous experiments on future behaviors. Mice had at least 3 days separating between consecutive tests. 
Approximately, a week after the end of all behavioral testing and when mice were 4-m old, they were euthanized 
for biochemical analysis. The tests conducted in this study have been summarized below and detailed information 
has been included in the Supplementary Methods.
Open field and spontaneous locomotor activity. Spontaneous motor activity and anxiety-related behavior were 
recorded with well-established methods17,19,20. In parallel, routine parameters of general motor behaviors (e.g., 
rearing, speed, number and length of individual movements) were measured, providing accurate quantification 
of general locomotor activity22.
Acoustic startle. The acoustic startle response is routinely used to assess anxiety levels and sensor-motor gating20.
Grip strength. The grip strength was employed to assess the neuromuscular function as maximal muscle 
strength of forelimbs and combined forelimbs and hind limbs21.
Treadscan (treadmill). The use of a treadmill to gather data for comprehensive, quantitative assessment of gait in 
mice is a sensitive method to evaluate motor performance. The computer-assisted footprint analysis assessed gait 
characteristics such as velocity, stance time, swing time, and stride length as the animal traverses a clear stationary 
walkway76.
Rotarod. This analysis was performed with the use of a Rotamex-5 4 Lane Rota-Rod for Mice with Photocell 
Detection (Columbus Instruments, Columbus, OH) in the dark phase and it was used to measure the latency of 
mice to fall from the rotating rod. One-training and three test sessions were performed the first day and then 
three test sessions per day for the next two days. For the training session animals were loaded onto rotating rod 
and tested for 120 s at 4 rpm. After 120 s, mice were removed, place in home cage for 60 s and test session started. 
Animals were loaded on the rotating rod and allowed to grasp the cylinder and begin a running motion. During 
each session, rod accelerated 1 rpm/10 s to a max of 40 rpm. If mice “clung” to the axle, and to prevent bias these 
were removed after three consecutive rotations and the latency at that time was used as the score for that animal. 
Tray and rod were cleaned with 10% Nolvolsan between groups of 4 and between days.
Passive avoidance. The passive avoidance test was performed as described70 to evaluate the learning capability 
of the three groups of mice.
Protein S-palmitoylation quantification. Assessment of palmitoylation levels were carried out in cer-
ebella from 4-m old mice and NPC samples as previously described by utilizing the acyl-biotin exchange assay3. 
More details are reported in the Supplementary Methods.
Isolation of mitochondria from mouse brains. Enriched mitochondrial fractions were obtained from 
cortex and cerebellum of 4-month old and 2-y mice by mechanical cell disruption using a glass-Teflon homoge-
nizer and subsequent centrifugation as previously described77. The enrichment of mitochondria in the mitochon-
dria fraction was in the range of 30 to ~300-fold as judged by the ratios of mitochondrial over cytosolic markers 
(Supplementary Table S1). The mitochondria-enriched fraction was resuspended in hypo-osmotic 20 mM HEPES 
buffer, pH 7.4, supplemented with phosphatase inhibitors (Sigma #P0044) and proteolytic inhibitors (Sigma 
#P2714), and stored at −80 °C. A fraction of the mitochondria-enriched samples were further centrifuged at 
16,000 g for 10 min and pellet (mitochondria membrane fractions) was resuspended in RIPA buffer for the quanti-
fication of membrane-bound palmitoyl-Drp1 levels (see below). Protein concentration was evaluated using a BCA 
Protein assay kit (Pierce) following manufacturer’s recommendation. Absorbance was recorded at 560 nm with the 
use of a Tecan Infinite M200 plate reader (Tecan, Austria). Other details were included in Supplementary Methods.
Mitochondrial outcomes in NPC and cerebellum and cortex from luc mice. Protein extracts for 
enzymatic analyses were obtained by resuspending brain mitochondria (2–5 µg) or NPC in a hypotonic buffer 
(20 mM HEPES, pH 7.4) from 4-m and 2-y old mice and homogenizing the suspension with 30 strokes with a 
hand homogenizer, followed by two cycles of freezing and thawing. NADH-decylubiquinone oxidoreductase 
(Complex I), cytochrome c oxidase (Complex IV), ATPase (Complex V), and citrate synthase activities were eval-
uated as described in detail elsewhere77,78. Absorbance changes were followed in a Tecan M200 microplate reader 
and analyzed with the Magellan software, version 6. Changes in mtDNA CN were evaluated by dual-labeled 
qPCR. The gene copy number of ND1 was normalized by a single-copy nuclear gene (pyruvate kinase) as 
explained in detail before78.
Cell culture conditions. Neuronal progenitor cells (NPC) were obtained from the CHDI repository pro-
gram and grown as previously described79. Other details are reported in the Supplementary Methods. HeLa cells 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS), 1% nonessen-
tial amino acids (NEAA) and 100 U/ml penicillin-streptomycin and incubated at 37 °C with 5% CO2.
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Evaluation of mitochondrial distribution and morphology. NPC (1 × 105) were seeded on ster-
ile coverslips, grown overnight at 33 °C, followed by incubation with 0.5 µM MitoTracker Red CMXRos 
(MolecularProbes Inc., Eugene, OR) diluted in growth media for 30 min at 33 °C as previously described79. HeLa 
cells were transfected with GFP-tagged WT and truncated form of Zdhhc13 (L203X). The coding sequences of 
both the WT and L203X mutant Zdhhc13 genes were unidirectionally cloned into the pEGFP-C1 vector (BD 
Biosciences, San Jose, CA) with the EGFP located in the N-terminal portion of the proteins. Transfection was 
confirmed by regular fluorescence microscopy. Seventy-two h after transfection cells were incubated with 0.5 µM 
MitoTracker Red CMXRos for 30 min at 37 °C and then washed three times with growth medium. Subsequently, 
cells were fixed with methanol for 20 min at −20 °C and later permeabilized with 5% newborn calf serum and 0.3% 
Triton X-100 in PBS for 30 min. Cells were then counterstained with DAPI for imaging with a ZeissObserverZ1 
confocal microscope (CarlZeissMicroImagingInc., Thornwood,NY) or with an Olympus FV1000 laser scanning 
confocal microscope. Other details are reported in the Supplementary Methods.
Zdhhc13-Drp1 protein-protein interaction. Kinetic parameters for the interaction of Drp1 with WT 
and truncated form of Zdhhc13 (L203X) were obtained with the use of an Octet RED384 system (Pall ForteBio, 
Menlo Park, CA). Briefly, purified recombinant WT (culture supernatant) and truncated Zdhhc13 (culture elu-
ate) proteins were both produced by using the mouse Zdhhc13 sequence (UniProtKB: Q9CWU2). A GST-tagged 
recombinant, purified Drp1 (Novus Biologicals, # H00010059-P01) was immobilized onto a ForteBio biosensor, 
equipped with a high affinity pre-immobilized anti-GST antibody. Upon binding of the recombinant GST-tagged 
Drp1, the biosensor was exposed to either recombinant WT or mutant Zdhhc13 (bait proteins). The association 
and dissociation of bait proteins was monitored in parallel.
In vivo co-immunoprecipitation experiments were performed in total brains from WT and HOM mice 
homogenized in RPMI added with proteases and phosphatases inhibitors. One mg of total lysate was incu-
bated with either an anti-Drp1 antibody (Cell Signaling; 1:100 dilution) or an anti-Zdhhc13 antibody (#4733, 
custom-made by Pacific Immunology, Ramona, CA; 1:50 dilution) overnight at 4 °C under gentle rocking. 
Subsequently, magnetic beads obtained from 50 µl of a Dynabeads suspension (Invitrogen) were added to the 
lysate-ab complexes and incubated at 20–22 °C for 30 min. Tubes were then placed on a magnet and supernatant 
discarded. Dynabeads-Ab-Ag complexes were then washed 3 times with PBS and finally added in loading buffer 
containing 50 mM dithiothreitol and heated at 70 °C for 10 m. Tubes were again placed on a magnet and super-
natant collected and loaded in a 4–12% Bis-Tris gel and ran as previously described3,79. Proteins were then trans-
ferred onto a nitrocellulose membrane with the use of the iBlot system, blocked for 1 h at 20–22 °C with Li-COR 
blocking buffer and then incubated with the primary anti-Drp1 antibody (1:1000 dilution) overnight at 4 °C. 
Membranes were then washed 4 x for 5 min with TBST and then incubated with IRDye 800CW goat anti-rabbit 
antibody (LI-COR), diluted 1:10,000 for 1 h at 20–22 °C. Proteins were finally visualized with an Odyssey infrared 
imaging system LI-COR and densitometry performed with ImageJ. The antibody heavy chain bands at 55 kD 
were used as loading controls. In paralle, immunoprecipitation of proteins by using antibodies directed to Drp1 
or Zdhcc13 was performed with whole brains from WT and HOM mice. The resulting pellets were subjected to 
mass spectrometry. All other details are under Supplementary Table S2.
Statistical analysis. Statistical analysis of the data across the 3 genotypes was performed by ANOVA, fol-
lowed by Bonferroni’s post-hoc test. To evaluate the contribution of time, genotype and brain area on the observed 
differences in mitochondrial outcomes a 2-way ANOVA was performed, followed by Bonferroni’s post-hoc test 
for individual comparisons. In all other instances an unpaired, two-tailed Student’s t test was employed.
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